[1] Dana Farber Canc Inst, Boston, MA USA
[2] Univ Hosp, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic
[3] Fac Med, Hradec Kralove, Czech Republic
[4] Univ Barcelona, IDIBELL, Inst Catala Oncol, Hosp Duran i Reynals, Barcelona, Spain
[5] Univ Helsinki, Helsinki, Finland
[6] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland
[7] Leiden Univ, Med Ctr, Leiden, Netherlands
[8] Oslo Univ Hosp, Oslo, Norway
[9] KG Jebsen Ctr B Cell Malignancies, Oslo, Norway
[10] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[11] Erasmus MC Canc Inst, Univ Med Ctr, Dept Hematol, Lunenburg Lymphoma Phase Consortium HOVON LLPC 1, Rotterdam, Netherlands
[12] Ronald Reagan Univ Calif Los Angeles Med Ctr, Los Angeles, CA USA
[13] Hosp Univ Vall dHebron, Barcelona, Spain
[14] Univ Med Ctr Groningen, Groningen, Netherlands
[15] Univ Groningen, Groningen, Netherlands
[16] Odense Univ Hosp, Odense, Denmark
[17] Karolinska Inst, Stockholm, Sweden
[18] Christie NHS Fdn Trust, Manchester, Lancs, England
[19] Manchester Canc Res Ctr, Manchester, Lancs, England
[20] Genmab, Plainsboro, NJ USA
[21] AbbVie, N Chicago, IL USA
[22] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, New York, NY USA